Top

Published in:

01-12-2018

Correlates of smoking status in cancer survivors

Authors: Melissa A. Little, Robert C. Klesges, Zoran Bursac, Jennifer P. Halbert, Jon Ebbert, Gerald W. Talcott, Benny Weksler

Published in: Journal of Cancer Survivorship | Issue 6/2018

Abstract

Purpose

To determine the characteristics associated with cancer survivors which indicate continued cigarette smoking at or around the time of cancer diagnosis.

Methods

A total of 631 survivors were recruited in four cancer centers in Memphis, TN, between March 2015 and June 2016. To increase the probability of accurate reporting, surveys were conducted anonymously. A total of 112 respondents reported they were current smokers and 202 reported they were former smokers (n = 314), who comprised the sample.

Results

We found that the rate of daily e-cigarette use among cancer survivors who smoked was 15.2% versus 3.9% in cancer survivors who no longer smoked. The national rate of adult e-cigarette use is 3.5%. Multivariate models correlated the characteristics of current versus former smokers and revealed that increasing age (aOR = 0.97, p < .0001), decreasing education (aOR = 2.39, p < .02), and current use of e-cigarettes (aOR = 3.74, p < .00045) were frequently associated with current cigarette smoking.

Conclusions

While age and gender were associated with continued smoking, current use of e-cigarettes was associated with almost four times higher odds of being a current smoker. Further research is needed to determine if use of e-cigarettes deters or promotes the smoking cessation process, at least in cancer survivors.

Implications for Cancer Survivors

Among cancer survivors who continue to smoke after a cancer diagnosis, use of e-cigarettes is highly prevalent; research is needed to determine whether use of e-cigarettes promotes, has no effect, or hinders smoking cessation efforts among this vulnerable population.

U.S. Department of Health and Human Services. The health consequences of Smoking—50 years of progress: A report of the surgeon general. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.

Centers for Disease Control and Prevention (CDC). Fact sheet: Current cigarette smoking among adults in the United States. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm. Updated 2016. Accessed 09/04, 2017.

Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809841/. https://doi.org/10.1136/bmj.b5569.CrossRefPubMedPubMedCentral

Adhikari B, Kahende J, Malarcher A, Pechacek T, Tong V. Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008;57(45):1226–8 http://www.proxy.its.virginia.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=105715504&site=ehost-live&scope=site.

NCI dictionary of cancer terms. https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=450125. Accessed 14 Aug 2017.

American Cancer Society. Cancer treatment & survivorship facts & figures 2016–2017. Atlanta: American Cancer Society; 2016. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2016-2017.pdf. Accessed 20 Nov 2017

Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer. 2003;98(3):632–44. https://doi.org/10.1002/cncr.11538.CrossRefPubMed

de Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomark Prev. 2013;22(4):561. http://cebp.aacrjournals.org/content/22/4/561.abstract–70.CrossRef

Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328(3):159–63. https://doi.org/10.1056/NEJM199301213280302.CrossRefPubMed

10.

Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, et al. EGFR, p16, HPV titer, bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26(19):3128–37. https://doi.org/10.1200/JCO2007.12.7662.CrossRefPubMed

11.

Florou AN, Gkiozos IC, Tsagouli SK, Souliotis KN, Syrigos KN. Clinical significance of smoking cessation in subjects with cancer: A 30-year review. Respir Care. 2014;59(12):1924–36. https://doi.org/10.4187/respcare.02559.CrossRefPubMed

12.

Nayan S, Gupta MK, Strychowsky JE, Sommer DD. Smoking cessation interventions and cessation rates in the oncology population. Otolaryngol Head Neck Surg. 2013;149(2):200–11. https://doi.org/10.1177/0194599813490886.CrossRefPubMed

13.

Schnoll RA, Calvin J, Malstrom M, Rothman RL, Wang H, Babb J, et al. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med. 2003;25(3):214–21. https://doi.org/10.1207/S15324796ABM2503_07.CrossRefPubMed

14.

Eng L, Su J, Qiu X, et al. Second-hand smoke as a predictor of smoking cessation among lung cancer survivors. J Clin Oncol. 2014;32(6):564–70. https://doi.org/10.1200/JCO.2013.50.9695.CrossRefPubMed

15.

Ostroff JS, Jacobsen PB, Moadel AB, Spiro RH, Shah JP, Strong EW, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75(2):569–76.CrossRefPubMed

16.

Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119–27.CrossRefPubMed

17.

Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current cigarette smoking among adults—United States, 2005–2015. MMWR Morb Mortal Wkly Rep. 2016;65(44):1205–11. http://www.proxy.its.virginia.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=119452652&site=ehost-live&scope=site. https://doi.org/10.15585/mmwr.mm6544a2.CrossRefPubMed

18.

Garrett BE, Dube SR, Trosclair A, Caraballo RS, Pechacek TF. Centers for Disease Control and Prevention (CDC). Cigarette smoking—United States, 1965-2008. MMWR Suppl. 2011;60(1):109–13.PubMed

19.

Singh T, Arrazola RA, Corey CG, et al. Tobacco use among middle and high school students—United States, 2011–2015. MMWR Morb Mortal Wkly Rep. 2016;65(14):361–7. https://doi.org/10.15585/mmwr.mm6514a1.CrossRefPubMed

20.

Tam J, Warner KE, Gillespie BW, Gillespie JA. Impact of changing U.S. demographics on the decline in smoking prevalence, 1980–2010. Nicotine Tob Res. 2014;16(6):864–6. https://doi.org/10.1093/ntr/ntt223.CrossRefPubMed

21.

Escobedo LG, Peddicord JP. Smoking prevalence in US birth cohorts: the influence of gender and education. Am J Public Health. 1996;86(2):231–6.CrossRefPubMedPubMedCentral

22.

Zhu BP, Giovino GA, Mowery PD, Eriksen MP. The relationship between cigarette smoking and education revisited: implications for categorizing persons’ educational status. Am J Public Health. 1996;86(11):1582–9.CrossRefPubMedPubMedCentral

23.

Lillard DR, Plassmann V, Kenkel D, Mathios A. Who kicks the habit and how they do it: socioeconomic differences across methods of quitting smoking in the USA. Soc Sci Med. 2007;64(12):2504–19. https://doi.org/10.1016/j.socscimed.2007.02.036.CrossRefPubMedPubMedCentral

24.

Wagenknecht LE, Perkins LL, Cutter GR, Sidney S, Burke GL, Manolio TA, et al. Cigarette smoking behavior is strongly related to educational status: the cardia study. Prev Med. 1990;19(2):158–69. https://doi.org/10.1016/0091-7435(90)90017-E.CrossRefPubMed

25.

Stringhini S, Sabia S, Shipley M, et al. Association of socioeconomic position with health behaviors and mortality. JAMA. 2010;303(12):1159–66. https://doi.org/10.1001/jama.2010.297.CrossRefPubMedPubMedCentral

26.

QuickStats: Cigarette smoking status* among current adult E-cigarette users,dagger by age group—national health interview survey, section sign United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(42):1177. https://doi.org/10.15585/mmwr.mm6542a7.

27.

Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Intern Med. 2014;174(5):812–3. https://doi.org/10.1001/jamainternmed.2014.187.CrossRefPubMedPubMedCentral

28.

Pericot-Valverde I, Gaalema DE, Priest JS, Higgins ST. E-cigarette awareness, perceived harmfulness, and ever use among U.S. adults. Prev Med. 2017;104:92–9. https://doi.org/10.1016/j.ypmed.2017.07.014.CrossRefPubMedPubMedCentral

29.

Giovenco DP, Delnevo CD. Prevalence of population smoking cessation by electronic cigarette use status in a national sample of recent smokers. Addict Behav. 2018;76:129–34. https://doi.org/10.1016/j.addbeh.2017.08.002.CrossRefPubMed

30.

Little MA, Bursac Z, Derefinko KJ, et al. Types of dual and poly-tobacco users in the US military. Am J Epidemiol. 2016;184(3):211–8. https://doi.org/10.1093/aje/kwv321.CrossRefPubMedPubMedCentral

31.

Tobacco Advisory Group of the Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0. Updated 2016. Accessed 09/04, 2017.

32.

Smokefree.gov. What we know about E-cigarettes. https://smokefree.gov/quitting-smoking/e-cigs-menthol-dip-more/what-we-know-about-e-cigarettes. Accessed 4 Sept 2017.

33.

Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016;9:CD010212. https://doi.org/10.1002/14651858.CD010216.pub3.CrossRef

34.

McNeill A, Brose L, Calder R, Hitchman S, Hajek P, McRobbie H. E-cigarettes: An evidence update. Public Health England 2015;3. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/733022/Ecigarettes_an_evidence_update_A_report_commissioned_by_Public_Health_En. Accessed 30 April 2018.

35.

Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: Association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17(2):127–33. https://doi.org/10.1093/ntr/ntu200.CrossRefPubMed

36.

Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016;4(2):116–28. https://doi.org/10.1016/S2213-2600(15)00521-4.CrossRefPubMedPubMedCentral

37.

Fidler JA, Shahab L, West O, et al. ‘The smoking toolkit study’: a national study of smoking and smoking cessation in England. BMC Public Health. 2011;11:479–2458–11-479. https://doi.org/10.1186/1471-2458-11-479.CrossRefPubMedPubMedCentral

38.

West R, Beard E, Brown J. Trends in electronic cigarette use in England. Smoking Toolkit Study: Latest Statistics. 2017(July 7). https://smokinginengland.info/latest-statistics/. Accessed 30 April 2018

39.

Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629–37. https://doi.org/10.1016/S0140-6736(13)61842-5.CrossRefPubMed

40.

Brandon TH, Goniewicz ML, Hanna NH, et al. Electronic nicotine delivery systems: A policy statement from the american association for cancer research and the american society of clinical oncology. J Clin Oncol. 2015;33(8):952–63. https://doi.org/10.1200/JCO.2014.59.4465.CrossRefPubMed

41.

Jamal A, Phillips E, Gentzke AS, et al. Current cigarette smoking among adults—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(2):53–9. https://doi.org/10.15585/mmwr.mm6702a1.CrossRefPubMedPubMedCentral

Title: Correlates of smoking status in cancer survivors
Authors: Melissa A. Little
Robert C. Klesges
Zoran Bursac
Jennifer P. Halbert
Jon Ebbert
Gerald W. Talcott
Benny Weksler
Publication date: 01-12-2018
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 6/2018
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-018-0720-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 6/2018

Barriers to physical activity: a study of academic and community cancer survivors with pain

Survivorship care planning in gynecologic oncology—perspectives from patients, caregivers, and health care providers

Smoking cessation among men following cancer diagnosis: a matched cohort study

Quality of diabetes care in breast, colorectal, and prostate cancer

A smoking cessation and pain management program for cancer survivors

Cognitive challenges while at work and work output in breast cancer survivors employed in a rapidly evolving economy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer